Thursday, October 2, 2014
Time | Event | |
09:00 - 13:15 | INTRODUCTORY PRESENTATIONS | |
09:00 - 09:45 | Pharmacokinetics and pharmacodynamic concepts - Tobias Paehler (Sanofi, Germany) | |
09:45 - 10:30 | Computational approaches for prediction/simulation of drug delivery - Tarek Mounir (University of Nancy, France) | |
10:30 - 11:00 | Coffee break | |
11:00 - 11:45 | In vitro/in vivo correlation: a biopharmaceutics tool used in drug development - Jean-michel Cardot, (University Clermont-Ferrand, France) | |
11:45 - 12:30 | Principles of Electroporation for drug delivery - Marie-Pierre Rols (University of Toulouse, France) | |
12:30 - 13:15 | Electroporation : characterization, tools, and constraints for in vivo delivery - Damijan Miklavcic (University of Ljubljana, Slovenia) | |
13:15 - 14:30 | Lunch break and Networking | |
14:30 - 17:15 | ORAL ROUTE | |
14:30 - 15:15 | Oral Drug Delivery: Physiological challenges for pharmaceutics - Clive Wilson (University of Strathclyde, UK) | |
15:15 - 16:00 | Computational models for Drug Delivery by Oral Administration. - Michael B. Bolger (Simulations Plus, California, USA) | |
16:00 - 16:30 | Coffee break | |
16:30 - 17:15 | In vitro models for assessment of oral drug absorption - Per Artursson (Uppsala University, Sweden) | |
17:15 - 18:30 | TBA - Short oral communications |
Friday, October 3, 2014
Time | Event | |
09:00 - 13:15 | PARENTERAL ROUTE 1: Intravenous (models/tools for drug delivery to cancer and to brain) | |
09:00 - 09:45 | Physiological barriers to drug delivery by i.v. route, clinical relevance, and challenges) - Jean-Marie Devoisselle (University of Montpellier, France) | |
09:45 - 10:30 | In vitro and in vivo models for drug delivery to cancer - Khaled Greish (University Otago, New Zealand) | |
10:30 - 11:00 | Coffee break | |
11:00 - 11:45 | Preclinical development of electrochemotherapy (ECT) for treatment of tumors. - Gregor Sersa (Institute of Oncology Ljubljana, Slovenia) | |
11:45 - 12:30 | Targeting the blood brain barrier to improve drug delivery to brain - Xavier Descleves, (University Paris Descartes, Paris, France) | |
12:30 - 13:15 | Challenges of using In vitro data for modeling P-glycoprotein efflux in the blood-brain barrier - Marjo Yliperttula (University of Helsinki, Finland) | |
13:15 - 14:30 | Lunch break and networking | |
14:30 - 16:30 | PARENTERAL ROUTE 1: Alternative routes: Pulmonary, Nasal and Cutaneous | |
14:30 - 15:15 | Drug delivery to the lungs: barriers, challenges and opportunities - Rita Vanbever (University of Louvain, Belgium) | |
15:15 - 15:45 | Coffee break | |
15:45 - 16:30 | In vitro models of pulmonary drug disposition - are we there yet? - Carsten Ehrhardt (University of Dublin, Ireland) | |
16:30 - 17:30 | TBA - Short Oral Communications |
Saturday, October 4, 2014
Time | Event | |
09:00 - 14:00 | PARENTERAL ROUTE 1: Alternative routes: Pulmonary, Nasal and Cutaneous | |
09:00 - 09:45 | Challenges in percutaneous drug delivery: Recent developments in formula and predicting tools - Begoña Delgado-Charro (University of Bath, United Kingdom) | |
09:45 - 10:30 | DNA electroporation for local delivery of therapeutic proteins and vaccines - Gaelle Vandermeulen (Université Catholique de Louvain, Belgium) | |
10:30 - 11:00 | Coffee break | |
11:00 - 11:45 | Current clinical experience on electroporation based treatments, and future prospects - Julie Gehl (Herlev Hospital, Copenhagen, Denmark) | |
11:45 - 12:30 | Nanomedicine revolution: the path through regulatory science into personalized medicine - Rogerio Gaspar (University of Lisbon, Portugal) |